225220 — Genolution Balance Sheet
0.000.00%
- KR₩40bn
- KR₩31bn
- KR₩7bn
Annual balance sheet for Genolution, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 48,957 | 45,936 | 46,380 | 42,754 | 33,212 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9,548 | 8,367 | 3,115 | 2,374 | 1,309 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 63,448 | 57,667 | 54,542 | 48,654 | 37,286 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 16,090 | 21,384 | 42,571 | 47,023 | 57,568 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 83,774 | 94,941 | 114,454 | 113,438 | 106,453 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15,836 | 12,649 | 4,644 | 10,075 | 5,822 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 22,483 | 12,738 | 19,755 | 25,988 | 26,165 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 61,291 | 82,203 | 94,699 | 87,450 | 80,288 |
Total Liabilities & Shareholders' Equity | 83,774 | 94,941 | 114,454 | 113,438 | 106,453 |
Total Common Shares Outstanding |